申请人:Eli Lilly and Company
公开号:US06358982B1
公开(公告)日:2002-03-19
The present invention relates to the potentiation of glutamate receptor function using certain heterocyclyl sulphonamide derivatives. It also relates to novel heterocyclyl sulphonamide derivatives, to processes for their preparation and to pharmaceutical compositions containing them.
本发明涉及使用某些杂环磺酰胺衍生物增强谷氨酸受体功能。它还涉及新型杂环磺酰胺衍生物,以及它们的制备方法和含有它们的药物组合物。